Skip to main content

Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back

Cel

Coping with breast cancer more and more becomes a major socio-economic challenge not least due to its constantly increasing incidence in the developing world. There is a growing need for novel strategies to improve understanding and capacity to predict resilience of women to the variety of stressful experiences and practical challenges related to breast cancer. This is a necessary step toward efficient recovery through personalized interventions. BOUNCE will bring together modeling, medical, and social sciences experts to advance current knowledge on the dynamic nature of resilience as it relates to efficient recovery from breast cancer. BOUNCE will take into consideration clinical, cancer-related biological, lifestyle, and psychosocial parameters in order to predict individual resilience trajectories throughout the cancer continuum and eventually increase resilience in breast cancer survivors and help them remain in the workforce and enjoy a better quality of life.
BOUNCE will deliver a unified clinical model of modifiable factors associated with optimal disease outcomes and will deploy a prospective multi-center clinical pilot at four major oncology centers (in Italy, Finland, Israel and Portugal), where a total of 660 women will be recruited in order to assess its clinical validity against crucial patient outcomes (illness progression, wellbeing, and functionality). The advanced computational tools to be employed will validate indices of patients’ capacity to bounce back during the highly stressful treatment and recovery period following diagnosis of breast cancer. The overreaching goal of BOUNCE is to incorporate elements of a dynamic, predictive model of patient outcomes in building a decision-support system used in routine clinical practice to provide physicians and other health professionals with concrete, personalized recommendations regarding optimal psychosocial support strategies.

Zaproszenie do składania wniosków

H2020-SC1-2016-2017

Zobacz inne projekty w ramach tego zaproszenia

Szczegółowe działanie

H2020-SC1-2017-CNECT-2

Koordynator

HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ
Wkład UE netto
€ 773 625,00
Adres
Stenbackinkatu 9
00029 Helsinki
Finlandia

Zobacz na mapie

Region
Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa
Rodzaj działalności
Research Organisations
Finansowanie spoza UE
€ 0,00

Uczestnicy (8)

IDRYMA TECHNOLOGIAS KAI EREVNAS
Grecja
Wkład UE netto
€ 738 875,00
Adres
N Plastira Str 100
70013 Irakleio

Zobacz na mapie

Region
Ηράκλειο Κρήτη Νησιά Αιγαίου
Rodzaj działalności
Research Organisations
Finansowanie spoza UE
€ 0,00
ISTITUTO EUROPEO DI ONCOLOGIA SRL
Włochy
Wkład UE netto
€ 385 600,00
Adres
Via Filodrammatici 10
20121 Milano

Zobacz na mapie

Region
Nord-Ovest Lombardia Milano
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finansowanie spoza UE
€ 0,00
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS
Grecja
Wkład UE netto
€ 487 500,00
Adres
Patission Str. 42
10682 Athina

Zobacz na mapie

Region
Κεντρικός Τομέας Αθηνών Aττική Αττική
Rodzaj działalności
Research Organisations
Finansowanie spoza UE
€ 0,00
NHG FINLAND OY
Finlandia
Wkład UE netto
€ 747 435,00
Adres
Vattuniemenranta 2
00210 Helsinki

Zobacz na mapie

Region
Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finansowanie spoza UE
€ 0,00
THE HEBREW UNIVERSITY OF JERUSALEM
Izrael
Wkład UE netto
€ 557 000,00
Adres
Edmond J Safra Campus Givat Ram
91904 Jerusalem

Zobacz na mapie

Rodzaj działalności
Higher or Secondary Education Establishments
Finansowanie spoza UE
€ 0,00
SINGULARLOGIC ANONYMI ETAIREIA PLIROFORIAKON SYSTIMATON KAI EFARMOGONPLIROFORIKIS
Grecja
Wkład UE netto
€ 448 125,00
Adres
Achaias 3 & Troizinias
14564 Nea Kifisia

Zobacz na mapie

Region
Βόρειος Τομέας Αθηνών Aττική Αττική
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finansowanie spoza UE
€ 0,00
FUNDACAO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD
Portugalia
Wkład UE netto
€ 497 000,00
Adres
Avenida Brasilia, Centro De Investigacao Da Fundacao Champalimaud
1400-038 Lisboa

Zobacz na mapie

Region
Continente Área Metropolitana de Lisboa Área Metropolitana de Lisboa
Rodzaj działalności
Research Organisations
Finansowanie spoza UE
€ 0,00
VARIAN MEDICAL SYSTEMS FINLAND OY
Finlandia
Wkład UE netto
€ 364 250,00
Adres
Paciuksenkatu 21
00270 Helsinki

Zobacz na mapie

MŚP

Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.

Tak
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finansowanie spoza UE
€ 0,00